CUTISS Secures CHF 56 Million in Series C Funding for Innovative Skin Graft Technology CUTISS has successfully closed a CHF 56 million Series C funding round to advance its innovative skin graft technology, denovoSkin™, and enhance its production capabilities.

CUTISS Secures CHF 56 Million in Series C Funding for Innovative Skin Graft Technology #Switzerland #Zurich #CUTISS #denovoSkin #Rode_Kruis